Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Seonghoon | - |
dc.contributor.author | Yoon, Myonggeun | - |
dc.contributor.author | Chung, Weon Kuu | - |
dc.contributor.author | Chung, Mijoo | - |
dc.contributor.author | Kim, Dong Wook | - |
dc.date.accessioned | 2021-09-02T04:13:52Z | - |
dc.date.available | 2021-09-02T04:13:52Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2018-11 | - |
dc.identifier.issn | 0374-4884 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/71973 | - |
dc.description.abstract | We developed and evaluated an algorithm to calculate the target radiation dose in cancer patients by measuring the transmitted dose during 3D conformal radiation treatment (3D-CRT) treatment. The patient target doses were calculated from the transit dose, which was measured using a glass dosimeter positioned 150 cm from the source. The accuracy of the transit dose algorithm was evaluated using a solid water phantom for five patient treatment plans. We performed transit dose-based patient dose verification during the actual treatment of 34 patients who underwent 3D-CRT. These included 17 patients with breast cancer, 11 with pelvic cancer, and 6 with other cancers. In the solid water phantom study, the difference between the transit dosimetry algorithm with the treatment planning system (TPS) and the measurement was -0.10 +/- 1.93%. In the clinical study, this difference was 0.94 +/- 4.13% for the patients with 17 breast cancers, -0.11 +/- 3.50% for the eight with rectal cancer, 0.51 +/- 5.10% for the four with bone cancer, and 0.91 +/- 3.69% for the other five. These results suggest that transit-dosimetry-based in-room patient dose verification is a useful application for 3D-CRT. We expect that this technique will be widely applicable for patient safety in the treatment room through improvements in the transit dosimetry algorithm for complicated treatment techniques (including intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT)). | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN PHYSICAL SOC | - |
dc.subject | DOSIMETRY | - |
dc.subject | DETECTOR | - |
dc.title | Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Myonggeun | - |
dc.identifier.doi | 10.3938/jkps.73.1571 | - |
dc.identifier.scopusid | 2-s2.0-85057082907 | - |
dc.identifier.wosid | 000451051900026 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN PHYSICAL SOCIETY, v.73, no.10, pp.1571 - 1576 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN PHYSICAL SOCIETY | - |
dc.citation.title | JOURNAL OF THE KOREAN PHYSICAL SOCIETY | - |
dc.citation.volume | 73 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1571 | - |
dc.citation.endPage | 1576 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Physics | - |
dc.relation.journalWebOfScienceCategory | Physics, Multidisciplinary | - |
dc.subject.keywordPlus | DOSIMETRY | - |
dc.subject.keywordPlus | DETECTOR | - |
dc.subject.keywordAuthor | Transit dosimetry | - |
dc.subject.keywordAuthor | Glass dosimeter | - |
dc.subject.keywordAuthor | Clinical test | - |
dc.subject.keywordAuthor | 3D-CRT | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.